The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative trastuzumab and pertuzumab in combination with FLOT versus FLOT alone for HER2-positive resectable esophagogastric adenocarcinoma: Final results of the PETRARCA multicenter randomized phase II trial of the AIO.
 
Ralf Dieter Hofheinz
Honoraria - Amgen; Bristol-Myers Squibb; Lilly; Medac; Merck Serono; MSD; Roche; Sanofi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Roche; Sanofi
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Lilly; Merck; MSD; Roche; Sanofi; SERVIER
Research Funding - German Cancer Aid (Inst); Medac (Inst); Sanofi (Inst)
 
Georg Martin Haag
Consulting or Advisory Role - Bristol-Myers Squibb (Inst); EsoCap Biotech; MSD Oncology (Inst)
Speakers' Bureau - SERVIER
Research Funding - MSD Oncology (Inst); Nordic Group (Inst); Taiho Pharmaceutical (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb (Inst); Lilly (Inst)
 
Thomas Jens Ettrich
Consulting or Advisory Role - Bayer; Bayer; Bristol-Myers Squibb; Bristol-Myers Squibb; Eisai; Lilly; Merck Serono; MSD; MSD; Roche; Roche; Roche; Roche; Sanofi; Sanofi; Sanofi/Aventis
Research Funding - Baxalta/Shire
Travel, Accommodations, Expenses - Ipsen; Ipsen
 
Kersten Borchert
Consulting or Advisory Role - Amgen; Celgene; Merck; Roche; Sanofi; SERVIER
Travel, Accommodations, Expenses - Amgen; Celgene; Roche
 
Albrecht Kretzschmar
Honoraria - Amgen; Eisai; Medac; Merck Serono; Novartis; Roche Pharma AG; Sanofi; SERVIER; Shire
Consulting or Advisory Role - Amgen; Roche Pharma AG; Shire; Teva
Travel, Accommodations, Expenses - Ipsen; Medac; Merck Serono; PharmaMar
 
Christian Teschendorf
No Relationships to Disclose
 
Gabriele Margareta Siegler
Honoraria - Eisai; Janssen-Cilag; medizinwelten services GmbH; Roche; Shire
Research Funding - Beigene (Inst); Celgene (Inst); Isofol Medical (Inst); MOLOGEN (Inst); Novartis (Inst); Nutricia (Inst); Roche (Inst); Roche/Genentech (Inst); Sanofi (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Lilly
 
Matthias Philip Ebert
No Relationships to Disclose
 
Eray Goekkurt
Consulting or Advisory Role - Bristol-Myers Squibb; MSD; Roche; Sanofi; SERVIER
 
Manfred Welslau
No Relationships to Disclose
 
Rolf Mahlberg
Employment - Mutterhaus der Borromaeerinnen
Honoraria - Amgen; Novartis; Roche
Travel, Accommodations, Expenses - Amgen; Merck; Pfizer
 
Nils Homann
No Relationships to Disclose
 
Daniel Pink
Employment - Helios Kliniken GmbH
Consulting or Advisory Role - Clinigen Group (Inst); Lilly (Inst); Roche (Inst)
Research Funding - Clinigen Group (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Roche (Inst)
 
Wolf Otto Bechstein
Honoraria - Astellas Pharma; Baxter; Chiesi; Integra LifeSciences; MCI Group; MCI Group; Medupdate; Merck Serono; Teva
Consulting or Advisory Role - Astellas Pharma; Novartis
Speakers' Bureau - Integra LifeSciences
Travel, Accommodations, Expenses - Astellas Pharma; Baxter; Chiesi; Integra LifeSciences; MCI Deutschland; Medupdate; Merck Serono; Novartis; Teva
 
Peter Reichardt
Honoraria - Amgen; Bayer; Lilly; Novartis; Pfizer; PharmaMar
Consulting or Advisory Role - Bayer; Clinigen Group; Deciphera; Lilly; Novartis; Pfizer; PharmaMar; Roche
Research Funding - Novartis (Inst)
 
Timo Gaiser
No Relationships to Disclose
 
Disorn Sookthai
No Relationships to Disclose
 
Claudia Pauligk
No Relationships to Disclose
 
Thorsten Oliver Goetze
Consulting or Advisory Role - Bayer; Lilly; MSD Oncology; Roche; SERVIER
Speakers' Bureau - Lilly
Research Funding - Deutsche Forschungsgemeinschaft; Gemeinsamer Bundesausschuss
 
Salah-Eddin Al-Batran
Stock and Other Ownership Interests - IKF Klinische Krebsforschung
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Lilly; Merck; Merck Sharp & Dohme; Nordic Bioscience; Roche
Speakers' Bureau - AIO gGmbH; Celgene; Forum für Medizinische Fortbildung; Lilly; MCI group; Nordic Bioscience
Research Funding - Celgene; Federal Ministry of Education and Research; German Cancer Aid; German Research Foundation; Hospira; Lilly; Medac; Merck; Roche; Sanofi; Vifor Pharma